follow us:Google+ FacebookLinkedInTwitterRSS Feeds

advertisement

Soligenix closes $7.1M public offering

By

Back to Top Comments Email Print

News You Can Use

Latest News

advertisement

Princeton-based pharmaceutical company Soligenix announced today the closing of its $7.1 million public offering. The closing included 6. 7 million shares of common stock as well as five-year warrants to purchase up to 5.08 million shares of common.

Soligenix focuses on developing products to treat inflammatory diseases and biodefense countermeasures. According to the announcement, investors included an affiliated fund of Third Security LLC, a venture capital firm founded by R.J. Kirk and members of the company's management and board.

Share This Story On:

Write to the Editorial Department at editorial@njbiz.com

advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy

Advanced search
Sponsored by
advertisement
  
  
advertisement
  
  
advertisement
Back to Top